Ironwood Pharmaceuticals Inc (NAS:IRWD)
$ 4.485 0.295 (7.04%) Market Cap: 716.43 Mil Enterprise Value: 1.21 Bil PE Ratio: 112.13 PB Ratio: 0 GF Score: 51/100

Ironwood Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2023 / 05:00PM GMT
Release Date Price: $11.21 (-2.69%)
Daniel G. Wolle
JPMorgan Chase & Co, Research Division - Analyst

Good morning, everyone. My name is Daniel Wolle. I'm one of the analysts on this mid-cap biotech teams at JPMorgan. I'm delighted to continue the conference with Ironwood Pharmaceuticals. It's my pleasure to introduce Tom McCourt. Following his presentation, we'll have a Q&A session.

You can either ask the questions to the portal, and I can pass on to the management team, or you can raise your hand over via mic. All right. Without further ado, Tom?

Thomas A. McCourt
Ironwood Pharmaceuticals, Inc. - CEO & Director

Thanks, Daniel. And my name is Tom McCourt, I'm the CEO of Ironwood Pharmaceuticals, and I'm joined this morning by Sravan Emany, who's our Chief Financial Officer; and Mike Shetzline, who's our Chief Medical Officer. And we're absolutely delighted to be here this morning to share with you the progress that Ironwood's made in 2022 and why we're so excited about the path forward for 2023 and beyond.

We are focusing on advancing the organization, and many

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot